Skip to content
The Intraday
Pulse

Briefings

Morning BriefOvernight tape and the setup for the openMid-Morning UpdateWhat changed after the opening bell

Markets

Market DashboardTape, movers, watchlist, and cross-asset contextPre-Market SheetOvernight setup, futures, and early moversGlobal SessionsInternational clocks and index performanceInsider ActivityLatest reported executive transactions

ACH Research

Price ChartTechnical charting and drawing workspaceFundamentals ChartCompare financial metrics across timeCompany OverviewA visual snapshot of company performanceFinancial StatementsPrice, filings, key statistics, and news

Newsletter

Morning Production ReportRanked stories, charts, and newsletter readiness

Financial Statements

Explore

Markets, briefings, and company research

ACH
Pulse

Briefings

MorningMid-Morning

Markets

DashboardPre-MarketGlobalInsiders

ACH Research

ChartFundamentalsOverviewFinancials

Newsletter

Morning Report

Newsletter operations and account tools are available from your profile menu after sign-in.

Accendra Health, Inc.

ACH
$1.40
$-1.40 (-50.00%)-50.00%
Closed
Loading chart...
IndexN/A
Market Cap0.11B
Enterprise Value2.17B
Income$-0.02B
Sales$2.63B
EmployeesN/A
P/E2.06
P/S0.08
P/B-0.47
P/C-0.71
EV/EBITDA9.86
EV/SalesN/A
EPS (ttm)0.68
EarningsN/A
Gross Margin46.68%
Oper. Margin8.03%
Profit Margin-39.85%
Volume8.06M
Shs Outstand0.08B
Change-50.00%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
Income Statement by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Revenue$10.70B$10.33B$9.96B$9.79B$8.48B$9.21B$9.42B$9.32B
Cost of Revenue$8.48B$8.21B$8.13B$8.27B$7.20B$8.08B$8.35B$8.15B
Gross Profit$2.22B$2.13B$1.83B$1.51B$1.28B$1.13B$1.07B$1.17B
Gross Margin20.74%20.56%18.35%15.46%15.10%12.25%11.37%12.58%
Operating Expenses$2.43B$2.02B$1.68B$1.14B$1.08B$1.06B$1.42B$1.08B
Operating Income$-207.77M$104.51M$142.91M$368.47M$204.12M$73.15M$-352.35M$89.25M
Operating Margin-1.94%1.01%1.44%3.77%2.41%0.79%-3.74%0.96%
Net Income$-362.69M$-41.30M$22.39M$221.59M$29.87M$-62.37M$-437.01M$72.79M
Net Margin-3.39%-0.40%0.22%2.26%0.35%-0.68%-4.64%0.78%
EPS (Basic)$-118.25$-13.50$7.50$76.25$11.75$-9.25$-182.00$30.00
EBITDAN/AN/AN/AN/AN/AN/AN/AN/A
Stock Option Compensation ExpenseN/AN/AN/AN/AN/AN/AN/AN/A
Price To Earnings RatioN/AN/AN/AN/AN/AN/AN/AN/A
Price To Sales RatioN/AN/AN/AN/AN/AN/AN/AN/A
Shares OutstandingN/AN/AN/AN/AN/AN/AN/AN/A
Market CapitalizationN/AN/AN/AN/AN/AN/AN/AN/A
Balance Sheet by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Cash & Short Term InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Short Term ReceivablesN/AN/AN/AN/AN/AN/AN/AN/A
InventoriesN/AN/AN/AN/AN/AN/AN/AN/A
Other Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Net Property, Plant & EquipmentN/AN/AN/AN/AN/AN/AN/AN/A
Total Investments and AdvancesN/AN/AN/AN/AN/AN/AN/AN/A
Long-Term Note ReceivableN/AN/AN/AN/AN/AN/AN/AN/A
Intangible AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Other AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Assets$4.66B$5.09B$5.39B$3.54B$3.34B$3.64B$3.77B$3.38B
Short Term Debt Incl. Current Port. of LT DebtN/AN/AN/AN/AN/AN/AN/AN/A
Accounts PayableN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax PayableN/AN/AN/AN/AN/AN/AN/AN/A
Other Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Provision for Risks ChargesN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Other LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Liabilities$4.09B$4.17B$4.44B$2.60B$2.62B$3.18B$3.26B$2.36B
Non-Equity ReservesN/AN/AN/AN/AN/AN/AN/AN/A
Preferred Stock - Carrying ValueN/AN/AN/AN/AN/AN/AN/AN/A
Common EquityN/AN/AN/AN/AN/AN/AN/AN/A
Total Shareholders Equity$565.23M$924.17M$945.60M$938.50M$712.05M$462.15M$518.42M$1.02B
Accumulated Minority InterestN/AN/AN/AN/AN/AN/AN/AN/A
Total Equity$565.23M$924.17M$945.60M$938.50M$712.05M$462.15M$518.42M$1.02B
Total Liabilities & Stockholders Equity$4.66B$5.09B$5.39B$3.54B$3.34B$3.64B$3.77B$3.38B
Book Value Per ShareN/AN/AN/AN/AN/AN/AN/AN/A
Tangible Book Value Per ShareN/AN/AN/AN/AN/AN/AN/AN/A
Full-Time EmployeesN/AN/AN/AN/AN/AN/AN/AN/A
Price to Book RatioN/AN/AN/AN/AN/AN/AN/AN/A
Return on AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Return on EquityN/AN/AN/AN/AN/AN/AN/AN/A
Return on Invested CapitalN/AN/AN/AN/AN/AN/AN/AN/A
Quick RatioN/AN/AN/AN/AN/AN/AN/AN/A
Current RatioN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Net Income$-362.69M$-41.30M$22.39M$221.59M$29.87M$-62.37M$-437.01M$72.79M
DepreciationN/AN/AN/AN/AN/AN/AN/AN/A
Other Funds (Non Cash)N/AN/AN/AN/AN/AN/AN/AN/A
Funds from OperationsN/AN/AN/AN/AN/AN/AN/AN/A
Extraordinary ItemN/AN/AN/AN/AN/AN/AN/AN/A
Changes in Working CapitalN/AN/AN/AN/AN/AN/AN/AN/A
Income Taxes PayableN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Operating Activities$161.50M$740.71M$325.01M$124.18M$339.22M$166.09M$115.59M$56.77M
Capital ExpendituresN/AN/AN/AN/AN/AN/AN/AN/A
Net Assets From AcquisitionsN/AN/AN/AN/AN/AN/AN/AN/A
Sale of Fixed Assets and BusinessesN/AN/AN/AN/AN/AN/AN/AN/A
Purchase or Sale of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Purchase of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Sale Or Maturity of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Other UsesN/AN/AN/AN/AN/AN/AN/AN/A
Other SourcesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Investing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Cash Dividends PaidN/AN/AN/AN/AN/AN/AN/AN/A
Change in Capital StockN/AN/AN/AN/AN/AN/AN/AN/A
Repurchase of Common Pref StockN/AN/AN/AN/AN/AN/AN/AN/A
Sale of Common Pref StockN/AN/AN/AN/AN/AN/AN/AN/A
Proceeds from Stock OptionsN/AN/AN/AN/AN/AN/AN/AN/A
Issuance or Reduction of Debt, NetN/AN/AN/AN/AN/AN/AN/AN/A
Change in Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Issuance of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Reduction of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Net Financing Active Other Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A
Other Financing Activities UsesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Financing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Exchange Rate EffectN/AN/AN/AN/AN/AN/AN/AN/A
Net Change in CashN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A
Preferred Dividends (Cash Flow)N/AN/AN/AN/AN/AN/AN/AN/A
Price to Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A

Company coverage

Latest news

20 stories
Yesterday · 1:08PMAccendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcriptseekingalpha.com ↗Yesterday · 6:50AMAccendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Valuebusinesswire.com ↗Yesterday · 6:45AMAccendra Health Reports Second Quarter 2026 Financial Resultsbusinesswire.com ↗Yesterday · 6:30AMAccendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Searchbusinesswire.com ↗Jul 31 · 8:30AMCredova Expands Guidefitter Relationship, Bringing ACH Payments to Marketplace Checkout and the Guidefitter Walletbusinesswire.com ↗Jul 27 · 10:00AMAccendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Callgurufocus.com ↗Jul 27 · 9:15AMAccendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Callbusinesswire.com ↗Jul 2 · 10:06AMIs the Options Market Predicting a Spike in Accendra Health Stock?zacks.com ↗
Show 12 more stories↓
Jun 23 · 10:00PMAccendra Health Announces Expiration and Final Results of Offers and Consent Solicitationsgurufocus.com ↗Jun 23 · 9:15PMAccendra Health Announces Expiration and Final Results of Offers and Consent Solicitationsbusinesswire.com ↗Jun 10 · 7:00AMAccendra Health Announces Early Results of Offers and Consent Solicitationsgurufocus.com ↗Jun 10 · 6:30AMAccendra Health Announces Early Results of Offers and Consent Solicitationsbusinesswire.com ↗May 22 · 4:01PMAccendra Health Announces Offers and Consent Solicitationsbusinesswire.com ↗May 14 · 10:46AMAccendra Health, Inc. (ACH) Shareholder/Analyst Call Prepared Remarks Transcriptseekingalpha.com ↗May 11 · 2:33PMAccendra Health Makes Progress Addressing Its Debt Loadseekingalpha.com ↗May 11 · 1:30PMAccendra Health, Inc. (ACH) Q1 2026 Earnings Call Transcriptseekingalpha.com ↗May 11 · 6:30AMAccendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transactionbusinesswire.com ↗May 1 · 5:00PMAccendra Health Announces First Quarter 2026 Earnings Release Date and Conference Callbusinesswire.com ↗Mar 13 · 9:31AMIs the Options Market Predicting a Spike in Accendra Health Stock?zacks.com ↗Mar 3 · 10:00AMAlkami Now a Nacha Preferred Partner for ACH Experience, Fraud Monitoring, and Risk and Fraud Preventionprnewswire.com ↗

Insider Trading

No insider trades found for ACH.

Company

CEO: Edward A. PesickaEmployees: 6500www.accendrahealth.com
About the company↓

Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.

Discover more

You may be interested in
GOOGL

Alphabet Inc

$357.52

↑ 0.91%
MA

Mastercard Inc

$563.17

↑ 0.04%
PYPL

PayPal Holdings Inc

$59.07

↑ 0.00%
V

Visa Inc

$361.32

↓ 0.33%
DIS

Walt Disney Co

$103.19

↓ 1.63%
INTC

Intel Corp

$97.52

↓ 4.06%
BAC

Bank of America Corp

$63.86

↑ 1.09%
TSLA

Tesla Inc

$330.88

↑ 0.70%
NVDA

NVIDIA Corp

$217.55

↓ 2.86%
ADBE

Adobe Inc

$272.96

↑ 2.92%
AMD

Advanced Micro Devices

$469.56

↓ 2.86%
CRM

Salesforce Inc

$197.51

↑ 2.47%
The Intraday

© 2026 The Intraday. All rights reserved.

Market data may be delayedFor informational purposes onlyFMP · Massive · SEC